Limited time75% off all plans
Get the app

Cell Cycle and Regulation

Cell Cycle and Regulation

Cell Cycle and Regulation

On this page

Cell Cycle Phases - The Cellular Racetrack

The cell cycle orchestrates cell duplication. It consists of Interphase (G1, S, G2) and M phase.

  • Interphase: Preparatory phase for cell division.
    • G1 (Gap 1): Cell growth, protein & organelle synthesis. Longest & most variable phase. Restriction point commitment.
    • S (Synthesis): DNA replication. DNA content doubles ($\mathbf{2c} \rightarrow \mathbf{4c}$); chromosome number ($\mathbf{2n}$) unchanged. Histone synthesis.
    • G2 (Gap 2): Further growth, synthesis of microtubules (tubulin), preparation for mitosis.
  • M Phase (Mitosis): Nuclear division (karyokinesis) and cytoplasmic division (cytokinesis).
    • Phases: Prophase, Metaphase, Anaphase, Telophase (PMAT 📌).
    • Cytokinesis: Division of cytoplasm, forming two daughter cells.
  • G0 Phase (Quiescent): Resting state; cells have exited the cycle. Can be temporary or permanent (terminally differentiated, e.g., neurons, skeletal muscle).

⭐ Cells in G0 phase are metabolically active but non-proliferative; they can re-enter the cell cycle if stimulated by appropriate growth factors (e.g., lymphocytes).

Cyclins & CDKs - The Cycle's Conductors

  • Cyclins: Regulatory proteins; their levels oscillate, driving cell cycle progression. No intrinsic enzymatic activity.
  • CDKs (Cyclin-Dependent Kinases): Catalytic serine/threonine kinases; levels generally stable. Activated by binding specific cyclins, then phosphorylate target proteins.
  • Key Complexes & Roles:
    • Cyclin D + CDK4/6: Mid-G1 phase progression (mediates passage through Restriction point).
    • Cyclin E + CDK2: Late G1 to S transition; initiates DNA replication.
    • Cyclin A + CDK2: S phase progression and completion.
    • Cyclin B + CDK1 (MPF): G2 to M transition; drives mitosis (nuclear envelope breakdown, chromosome condensation). 📌 Mnemonic: "Drive Every Auto Bus" (Cyclins D, E, A, B for G1, G1/S, S, M phases respectively)
  • CDK Inhibitors (CKIs): Fine-tune CDK activity. Two families:
    • INK4 family (e.g., p16): Inhibit CDK4/6.
    • CIP/KIP family (e.g., p21, p27): Inhibit broad range of CDKs.

Cell cycle phases and Cyclin-CDK activity

MPF (Maturation Promoting Factor), composed of Cyclin B and CDK1, is crucial for initiating mitosis. Its activity peaks during metaphase and drops sharply at anaphase due to Cyclin B degradation via APC/C (Anaphase Promoting Complex/Cyclosome).

Checkpoints & Gatekeepers - Quality Control Central

Cell cycle checkpoints ensure genomic integrity, preventing errors that can lead to uncontrolled proliferation (cancer). Key proteins like p53 and Rb act as gatekeepers.

  • G1/S Checkpoint (Restriction Point): "Point of no return."
    • Monitors: DNA damage, cell size, nutrients, growth factors.
    • Key players: p53, Rb.
  • G2/M Checkpoint:
    • Monitors: DNA replication completion, DNA damage.
    • Ensures readiness for mitosis. MPF (Cdk1-Cyclin B) is crucial.
  • Spindle Assembly Checkpoint (SAC): (Metaphase-Anaphase)
    • Monitors: Kinetochore-microtubule attachment.
    • Prevents aneuploidy.

Cell Cycle Checkpoints and Regulation

⭐ p53, the "Guardian of the Genome," is mutated in over 50% of human cancers. Its activation triggers cell cycle arrest, senescence, or apoptosis.

Dysregulation & Disease - When Cycles Go Rogue

  • Cancer: Key outcome of dysregulation.
    • Uncontrolled proliferation, genomic instability, invasiveness.
  • Key Mechanisms:
    • Proto-oncogenes → Oncogenes: (e.g., Ras, MYC, Cyclin D) → Uncontrolled "Go" signals.
    • Tumor suppressors inactivated: (e.g., p53, Rb) → Loss of "Stop" signals.
      • p53 ("Guardian of Genome"): Mutations in >50% human cancers.
    • Checkpoint failure: DNA damage unrepaired, mutations accumulate.
  • Therapeutic Targets:
    • CDK inhibitors (e.g., Palbociclib for HR+ breast cancer).
    • Targeted therapies for specific oncoproteins (e.g., Imatinib). Cancer cells with nuclear atypia and mitotic figures

⭐ Li-Fraumeni syndrome: Inherited TP53 mutation; high risk of multiple cancers (sarcomas, breast, brain, leukemia).

High‑Yield Points - ⚡ Biggest Takeaways

  • Cyclin-CDK complexes drive cell cycle; specific pairs for phase transitions.
  • G1 checkpoint (Restriction point), regulated by Rb & p53, is key for commitment.
  • S phase: DNA replication. G2 checkpoint: checks DNA integrity pre-mitosis.
  • M phase checkpoint (Spindle assembly): checks chromosome segregation.
  • p53 (tumor suppressor) induces cell cycle arrest or apoptosis on DNA damage.
  • Rb protein inhibits E2F, blocking S phase entry; inactivated by G1 CDKs.
  • Cancer often involves p53/Rb mutations or cell cycle protein dysregulation.

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE